Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P27918: Variant p.Glu244Lys

Properdin
Gene: CFP
Feedback?
Variant information Variant position: help 244 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glutamate (E) to Lysine (K) at position 244 (E244K, p.Glu244Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PFD; type II; decreases expression, inhibits oligomerization and fails to stimulate bacteriolysis; does not affect binding to Complement C3 beta chain. Any additional useful information about the variant.


Sequence information Variant position: help 244 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 469 The length of the canonical sequence.
Location on the sequence: help CSAPEPSQKPPGKPCPGLAY E QRRCTGLPPCPVAGGWGPWG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         CSAPEPSQKPPGKPCPGLAYEQRRCTGLPPCPVAGGWGPWG

Mouse                         CSAPAPSHQPPGKPCSGPAYEHKACSGLPPCPVAGGWGPWS
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 28 – 469 Properdin
Domain 193 – 255 TSP type-1 3
Glycosylation 260 – 260 C-linked (Man) tryptophan
Glycosylation 263 – 263 C-linked (Man) tryptophan
Disulfide bond 205 – 248
Disulfide bond 209 – 254
Mutagenesis 244 – 244 E -> R. Inhibits oligomerization.
Beta strand 242 – 247



Literature citations
Functional and structural insight into properdin control of complement alternative pathway amplification.
Pedersen D.V.; Roumenina L.; Jensen R.K.; Gadeberg T.A.; Marinozzi C.; Picard C.; Rybkine T.; Thiel S.; Soerensen U.B.; Stover C.; Fremeaux-Bacchi V.; Andersen G.R.;
EMBO J. 36:1084-1099(2017)
Cited for: X-RAY CRYSTALLOGRAPHY (6.0 ANGSTROMS) OF 28-191 AND 256-469 IN COMPLEX WITH COMPLEMENT C3 BETA CHAIN; COMPLEMENT FACTOR B BB FRAGMENT AND STAPHYLOCOCCUS AUREUS PROTEIN SCN; FUNCTION; INTERACTION WITH COMPLEMENT C3 BETA CHAIN; SUBUNIT; SUBCELLULAR LOCATION; DOMAIN; VARIANT PFD LYS-244; CHARACTERIZATION OF VARIANT PFD LYS-244;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.